126
Participants
Start Date
December 31, 2013
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
MV ASV
Minute ventilation-targeted servo-ventilation therapy.
Optimized Medical Treatment
Beta Blockers, ACE inhibitor or ARB, loop diuretics and/or spironolactone as appropriate, statin if indicated, aspirin and/or warfarin if indicated
Penn State Hershey, Hershey
Jefferson Heart Institute, Philadelphia
University of Maryland, Baltimore
Sentara Cardiovascular Research Institute, Norfolk
Duke University Medical Center, Durham
Mercer University, Macon
The Heart Center, Huntsville
University of Cincinnati, Cincinnati
Northwestern University, Chicago
Washington University School of Medicine, St Louis
St. Luke's Hospital of Kansas City, Kansas City
VA Medical Center, Denver
VA Greater Los Angeles Healthcare System, Los Angeles
University of Washington, Seattle
Heart and Diabetes Center - North Rhine-Westphalia (HDZ-NRW), Bad Oeynhausen
Lead Sponsor
ResMed Foundation
OTHER
ResMed
INDUSTRY